Concepedia
Statistics
Publications
10
Citations
4.7K
H-Index
Active since
1999
Affiliations
Hamilton Health Sciences(Current)
Population Health Research Institute
McMaster University
Central Clinical Hospital
Medical University of South Carolina
W. Kamke is an author at Hamilton Health Sciences specializing in medicine, cardiology, and cardiovascular pharmacotherapy.
Publications per year
1999–2019
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text
Medicine, Endocrinology, Pharmacology +14
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction
Frank Edelmann, Rolf Wachter, Albrecht Schmidt et al. · JAMA · 2013 · 738 citations
Medicine, Cardiology, Pharmacology +17
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text
Medicine, Endocrinology, Nephrology +15
Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism
Ulrich Tebbe, Andreas Graf, W. Kamke et al. · American Heart Journal · 1999 · 139 citations
Medicine, Surgery, Hemodynamic Management +11
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes
M Hanefeld, Carsta Koehler, Christoph Hoffmann et al. · Diabetic Medicine · 2009 · 43 citations
Medicine, Endocrinology, Pharmacotherapy +17
1–5 of 10